Steve Williamson

882 total citations
10 papers, 69 citations indexed

About

Steve Williamson is a scholar working on Pediatrics, Perinatology and Child Health, Public Health, Environmental and Occupational Health and General Health Professions. According to data from OpenAlex, Steve Williamson has authored 10 papers receiving a total of 69 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pediatrics, Perinatology and Child Health, 4 papers in Public Health, Environmental and Occupational Health and 3 papers in General Health Professions. Recurrent topics in Steve Williamson's work include Pharmaceutical studies and practices (3 papers), Palliative Care and End-of-Life Issues (2 papers) and Mobile Health and mHealth Applications (1 paper). Steve Williamson is often cited by papers focused on Pharmaceutical studies and practices (3 papers), Palliative Care and End-of-Life Issues (2 papers) and Mobile Health and mHealth Applications (1 paper). Steve Williamson collaborates with scholars based in United Kingdom, Australia and United States. Steve Williamson's co-authors include Andy Husband, Adam Todd, Wasim Baqir, Jon Allen, Lee Tripcony, Michael Poulsen, Graeme Dickie, Chris Wratten, Jacqui Keller and Jonathan Ling and has published in prestigious journals such as PLoS ONE, Clinical Pharmacology & Therapeutics and Acta Oncologica.

In The Last Decade

Steve Williamson

9 papers receiving 65 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Steve Williamson United Kingdom	5	22	19	17	12	11	10	69
Jill Brufsky United States	5	9 0.4×	23 1.2×	14 0.8×	6 0.5×	46 4.2×	8	94
Cristina Carbonell Abella Spain	3	22 1.0×	10 0.5×	2 0.1×	7 0.6×	4 0.4×	8	52
William Bender United States	6	5 0.2×	11 0.6×	36 2.1×	3 0.3×	7 0.6×	17	107
Musarrat Nahid United States	6	11 0.5×	15 0.8×	6 0.4×	2 0.2×	6 0.5×	19	97
Emily Boucher United Kingdom	5	37 1.7×	23 1.2×	5 0.3×		5 0.5×	11	86
Tham Le United States	6	9 0.4×	4 0.2×	17 1.0×	7 0.6×	1 0.1×	16	65
Susana Herranz Spain	5	45 2.0×	28 1.5×	2 0.1×	16 1.3×	6 0.5×	9	81
Anna Svendsen Canada	3	7 0.3×	5 0.3×	10 0.6×	7 0.6×	3 0.3×	4	104
Christine Allmark United Kingdom	5	16 0.7×	9 0.5×	36 2.1×		49 4.5×	5	117
Lan Le United States	4	10 0.5×	5 0.3×	47 2.8×	8 0.7×		4	117

Countries citing papers authored by Steve Williamson

Since Specialization

Citations

This map shows the geographic impact of Steve Williamson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steve Williamson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steve Williamson more than expected).

Fields of papers citing papers by Steve Williamson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steve Williamson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steve Williamson. The network helps show where Steve Williamson may publish in the future.

Co-authorship network of co-authors of Steve Williamson

This figure shows the co-authorship network connecting the top 25 collaborators of Steve Williamson. A scholar is included among the top collaborators of Steve Williamson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steve Williamson. Steve Williamson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

1.

Kent, Seamus, et al.. (2025). Planning Post‐Launch Evidence Generation: Lessons From France, England and Spain. Clinical Pharmacology & Therapeutics. 117(4). 961–966. 2 indexed citations

2.

Tang, Diana, Melanie Ferguson, Kerry A. Sherman, et al.. (2024). Protocol for the co-design of an online support service for adults with hearing loss. PLoS ONE. 19(9). e0310521–e0310521.

3.

Williamson, Steve, et al.. (2014). Over compliance with capecitabine oral chemotherapy. International Journal of Clinical Pharmacy. 36(2). 271–273. 5 indexed citations

4.

Todd, Adam, et al.. (2013). Be Clear on Cancer: Pharmacy students' views of communicating with cancer patients. Durham Research Online (Durham University). 13. 1 indexed citations

5.

Todd, Adam, et al.. (2012). Patients with advanced lung cancer: is there scope to discontinue inappropriate medication?. International Journal of Clinical Pharmacy. 35(2). 181–184. 25 indexed citations

6.

Williamson, Steve, et al.. (2009). FMEA: a new approach to manage high risk medicines. Sunderland Repository (University of Sunderland). 1 indexed citations

7.

Williamson, Steve, et al.. (2006). Self-reported Injury History in Native American Professional Rodeo Competitors. Clinical Journal of Sport Medicine. 16(4). 352–354. 9 indexed citations

8.

Wratten, Chris, Michael Poulsen, Steve Williamson, et al.. (2002). Effect of Surgery on Normal Tissue Toxicity in Patients Treated with Accelerated Radiotherapy. Acta Oncologica. 41(1). 56–62. 12 indexed citations

9.

Meyers, Frederick J., Danika L. Lew, Primo N. Lara, et al.. (1998). Phase II trial of edatrexate in relapsed or refractory germ cell tumors: A Southwest Oncology Group study (SWOG 9124). Investigational New Drugs. 16(4). 347–351. 3 indexed citations

10.

Allen, Jon, et al.. (1997). Deliberate self-harm: developing clinical guidelines. Nursing Standard. 12(3). 34–37. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact